Trastuzumab envedotin

Product Description: Trastuzumab envedotin (DP303c) is a anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab envedotin is composed of the tubulin polymerization inhibitor Monomethyl auristatin E (MMAE) (HY-15162) to the anti-HER2 antibody DP001 via a cleavable linker. Trastuzumab envedotin can be used for the research of HER2-positive solid tumors, such as breast cancer, colorectal cancer, and gastric cancer[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Zhang J, et al. First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors. NPJ Precis Oncol. 2024 Sep 12;8(1):200.

Molecular Weight: N/A

Research Area: Cancer

Target: Antibody-Drug Conjugates (ADCs);EGFR

• Artikelnummer: MEXHY-172820-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-172820-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK